[ACRS] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 2.56%
YoY- -24.27%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 1,453 1,777 1,407 5,041 1,118 0 0 -
PBT -18,789 -28,754 -15,328 -37,565 -30,229 -12,559 -13,039 6.27%
Tax -1,318 16,439 -318 0 0 0 0 -
NP -17,471 -28,754 -15,586 -37,565 -30,229 -12,559 -13,039 4.99%
Tax Rate - - - - - - - -
Total Cost 18,924 30,531 16,993 42,606 31,347 12,559 13,039 6.40%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -1,202.41 -1,618.12 -1,107.75 -745.19 -2,703.85 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.28 -0.57 -0.37 -0.91 -0.98 -0.48 -0.65 -13.09%
EPS Diluted -0.28 -0.57 -0.37 -0.91 -0.98 -0.48 -0.65 -13.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.